v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 19,576 $ 16,415 $ 32,968 $ 29,476
General and administrative 7,403 4,651 14,310 9,556
Total operating expenses 26,979 21,066 47,278 39,032
Loss from operations (26,979) (21,066) (47,278) (39,032)
Interest income 1,825 1,185 3,807 2,518
Net loss $ (25,154) $ (19,881) $ (43,471) $ (36,514)
Net loss per share - basic and diluted (in dollars per share) $ (0.13) $ (0.14) $ (0.23) $ (0.26)
Basic and diluted weighted average shares outstanding (in shares) 186,798 138,282 186,600 138,259
Other comprehensive loss:        
Net loss $ (25,154) $ (19,881) $ (43,471) $ (36,514)
Unrealized (loss) gain on marketable securities (92) 18 (531) (2)
Comprehensive loss $ (25,246) $ (19,863) $ (44,002) $ (36,516)